Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
To amend sections 3902.50 and 3902.70; to amend, for the purpose of adopting a new section number as indicated in parentheses, section 3902.72 (3902.75); and to enact new section 3902.72 of the Revised Code to prohibit drug manufacturers from taking certain actions regarding reimbursements made to 340B covered entities.
Introduced
May 14, 2025
Last Action
May 21, 2025
Session
OH 136
Sponsors
2 primary · 0 co
Referred to committee
Introduced
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Referred to committee